LifeStance Health (LFST) Enterprise Value (2021 - 2025)
LifeStance Health (LFST) has disclosed Enterprise Value for 5 consecutive years, with -$248.6 million as the latest value for Q4 2025.
- On a quarterly basis, Enterprise Value fell 103.54% to -$248.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$248.6 million, a 103.54% decrease, with the full-year FY2025 number at -$248.6 million, down 103.54% from a year prior.
- Enterprise Value was -$248.6 million for Q4 2025 at LifeStance Health, down from -$141.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3.6 million in Q2 2024 to a low of -$276.2 million in Q2 2021.
- A 5-year average of -$117.4 million and a median of -$102.6 million in 2024 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: skyrocketed 97.48% in 2024, then crashed 5185.1% in 2025.
- LifeStance Health's Enterprise Value stood at -$148.0 million in 2021, then surged by 94.02% to -$8.9 million in 2022, then crashed by 823.58% to -$81.8 million in 2023, then crashed by 49.42% to -$122.2 million in 2024, then tumbled by 103.54% to -$248.6 million in 2025.
- Per Business Quant, the three most recent readings for LFST's Enterprise Value are -$248.6 million (Q4 2025), -$141.8 million (Q3 2025), and -$189.4 million (Q2 2025).